quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 29, 2026

Q1 Earnings Highs And Lows: The Marzetti Company (NASDAQ:MZTI) Vs The Rest Of The Shelf-Stable Food Stocks

View original at finance.yahoo.com
Q1 Earnings Highs And Lows: The Marzetti Company (NASDAQ:MZTI) Vs The Rest Of The Shelf-Stable Food Stocks Q1 Earnings Highs And Lows: The Marzetti Company (NASDAQ:MZTI) Vs The Rest Of The Shelf-Stable Food Stocks As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the shelf-stab…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Marzetti reported record-high gross profit in Q1 despite the decline in net sales.

    60% confidence

  • As a group, the 17 shelf-stable food stocks reported revenues in line with analyst consensus estimates for Q1, while next quarter revenue guidance was 11.6% below consensus.

    60% confidence

  • Retail segment gains were more than offset by category softness and reduced sales into the club channel.

    60% confidence

  • New York Bakery frozen garlic bread products continued to grow sales and increase market share in the Retail segment.

    60% confidence

  • Foodservice reported net sales increased 1.5% and Adjusted Foodservice Net Sales (excluding non-core TSA sales) grew 1.8%, led by higher demand from core national chain restaurant accounts.

    60% confidence

  • Shelf-stable food stocks have collectively declined; average share prices are down 3.2% since the latest earnings results.

    60% confidence

  • Sister Schubert's dinner roll sales benefited from pull-forward of demand due to the earlier Easter holiday.

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Q1 Earnings Highs And Lows: The Marzetti Company (NASDAQ:MZTI) Vs The Rest Of The Shelf-Stable Food Stocks — Source | Via News | pt.VIA.NEWS